Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice - PubMed (original) (raw)
. 1989 Mar 1;142(5):1523-7.
Affiliations
- PMID: 2465343
Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
V K Tuohy et al. J Immunol. 1989.
Abstract
PLP is the major protein constituent of central nervous system myelin. We have previously shown that SJL/J (H-2s) mice develop an acute form of EAE after immunization with PLP. The purpose of the present study was to identify an encephalitogenic determinant of PLP for SJL mice. We immunized SJL/J mice with a synthetic peptide identical to residues 130-147 QAHSLERVCHCLGKWLGH of murine PLP, a sequence having an amphipathic alpha-helical conformation. Although it did not induce disease, an overlapping peptide containing residues 139-154 HCLGKWLGHPDKFVGI was encephalitogenic. Immunization with this peptide induced severe clinical and histologic EAE in 3 of 20 mice. T cell enriched ILN cells from these mice responded specifically (3H-thymidine incorporation) to this peptide as well as to shorter analogues of this domain containing serine in place of cysteine at residues 138 and 140. Immunization with the serine-substituted PLP peptides 137-151 VSHSLGKWLGHPDKF and 139-151 HSLGKWLGHPDKF induced severe, acute EAE in 4 of 9 and 15 of 15 SJL mice, respectively, and their T cell enriched ILN cells responded not only to the analogues, but also to the native PLP sequence 139-154. These results indicate that residues 139-151 of murine PLP is an encephalitogenic determinant for SJL mice. Furthermore, like the PLP encephalitogenic domain for SWR (H-2q) mice, this determinant is also a T cell epitope with a coding sequence at the end of an exon.
Similar articles
- T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB. Kuchroo VK, et al. Annu Rev Immunol. 2002;20:101-23. doi: 10.1146/annurev.immunol.20.081701.141316. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861599 Review. - Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.
Tuohy VK. Tuohy VK. Neurochem Res. 1994 Aug;19(8):935-44. doi: 10.1007/BF00968703. Neurochem Res. 1994. PMID: 7528355 Review.
Cited by
- Active Induction of a Multiple Sclerosis-Like Disease in Common Laboratory Mouse Strains.
Orian JM, Maxwell DL, Lim VJT. Orian JM, et al. Methods Mol Biol. 2024;2746:179-200. doi: 10.1007/978-1-0716-3585-8_15. Methods Mol Biol. 2024. PMID: 38070090 - Immune Modulation by Antigenic Peptides and Antigenic Peptide Conjugates for Treatment of Multiple Sclerosis.
Mahadik R, Kiptoo P, Tolbert T, Siahaan TJ. Mahadik R, et al. Med Res Arch. 2022 May;10(5):10.18103/mra.v10i5.2804. doi: 10.18103/mra.v10i5.2804. Epub 2022 Jun 1. Med Res Arch. 2022. PMID: 36381196 Free PMC article. - The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review.
Saez-Calveras N, Brewster AL, Stuve O. Saez-Calveras N, et al. Front Mol Neurosci. 2022 Oct 13;15:1017484. doi: 10.3389/fnmol.2022.1017484. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311030 Free PMC article. Review. - Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.
Oxombre B, Madouri F, Journé AS, Ravez S, Woitrain E, Odou P, Duhal N, Ninni S, Montaigne D, Delhem N, Vermersch P, Melnyk P. Oxombre B, et al. Int J Mol Sci. 2022 Oct 6;23(19):11893. doi: 10.3390/ijms231911893. Int J Mol Sci. 2022. PMID: 36233193 Free PMC article. - Hedgehog Signaling in CNS Remyelination.
Fang M, Tang T, Qiu M, Xu X. Fang M, et al. Cells. 2022 Jul 21;11(14):2260. doi: 10.3390/cells11142260. Cells. 2022. PMID: 35883703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials